LEADER 03534nam  22006013u 450 
001 996339116203316
005 20230721022451.0
010   $a1-282-25517-7
010   $a9786612255175
010   $a1-84692-581-9
035   $a(CKB)1000000000788245
035   $a(EBL)456933
035   $a(OCoLC)436157575
035   $a(SSID)ssj0000826272
035   $a(PQKBManifestationID)11459615
035   $a(PQKBTitleCode)TC0000826272
035   $a(PQKBWorkID)10797862
035   $a(PQKB)11437113
035   $a(MiAaPQ)54794
035   $a(EXLCZ)991000000000788245
100   $a20130418d2009||||  u||            |
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aAcute Exacerbations in COPD$b[electronic resource]
210   $aOxford $cAtlas Medical Publishing Ltd$d2009
215   $a1 online resource (235 p.)
225 1 $aTherapeutic Strategies
300   $aDescription based upon print version of record.
311   $a1-904392-71-7 
327   $aContents; Editors; Contributors; Chapter 1: COPD exacerbations: definitions and classifications; Chapter 2: Infectious aetiologies in acute exacerbations of COPD; Chapter 3: Pathophysiology of COPD exacerbations; Chapter 4: Acute respiratory failure during exacerbation of COPD; Chapter 5: Effects of acute exacerbations on nutritional and metabolic profile in patients with COPD; Chapter 6: Outcomes in exacerbations of COPD; Chapter 7: Antibiotics in the treatment of acute exacerbations of COPD; Chapter 8: Antibiotics in COPD: pharmacokinetic/ pharmacodynamic dosing concepts
327   $aChapter 9: Acute exacerbations of COPD: application of evidence-based guidelinesChapter 10: Economic evaluation of antibiotic treatment of exacerbations of COPD; Chapter 11: Managing acute exacerbations in COPD with bronchodilators and corticosteroids; Chapter 12: Non-invasive positive pressure ventilation for the treatment of respiratory failure due to exacerbations of COPD; Chapter 13: 'Home hospitals' for acute exacerbations of COPD; Chapter 14: Prevention of acute exacerbations of COPD; Chapter 15: Novel therapeutic targets for acute COPD exacerbation; Abbreviations; Index
330   $aThe pronounced variability in the incidence and severity of chronic respiratory diseases such as asthma and COPD, makes effective treatment more difficult, and the social and economic costs of these diseases all the greater. Acute exacerbations are multi-factorial in origin, and are known to be linked with a number of agents including allergens, atmospheric pollution and infectious agents. Effective treatment requires a similarly complex approach that addresses each of the component causes. This text brings together current knowledge of the epidemiology and pathophysiology of these episodes, a
410  0$aTherapeutic Strategies
606   $aLungs -- Diseases, Obstructive -- Alternative treatment
606   $aLungs -- Diseases, Obstructive -- Diagnosis
606   $aLungs -- Diseases, Obstructive
615  4$aLungs -- Diseases, Obstructive -- Alternative treatment.
615  4$aLungs -- Diseases, Obstructive -- Diagnosis.
615  4$aLungs -- Diseases, Obstructive.
676   $a616.24
700   $aCazzola$b M$01014185
702   $aBlasi$b F
702   $aAnzueto$b Antonio
801  0$bAU-PeEL
801  1$bAU-PeEL
801  2$bAU-PeEL
906   $aBOOK
912   $a996339116203316
996   $aAcute Exacerbations in COPD$92362039
997   $aUNISA